Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 134

1.

Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder--a multicenter trial.

DeVeaugh-Geiss J, Moroz G, Biederman J, Cantwell D, Fontaine R, Greist JH, Reichler R, Katz R, Landau P.

J Am Acad Child Adolesc Psychiatry. 1992 Jan;31(1):45-9.

PMID:
1537780
[PubMed - indexed for MEDLINE]
2.

Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.

Freeman CP, Trimble MR, Deakin JF, Stokes TM, Ashford JJ.

J Clin Psychiatry. 1994 Jul;55(7):301-5.

PMID:
8071291
[PubMed - indexed for MEDLINE]
3.

Clomipramine in the treatment of patients with obsessive-compulsive disorder. The Clomipramine Collaborative Study Group.

[No authors listed]

Arch Gen Psychiatry. 1991 Aug;48(8):730-8.

PMID:
1883256
[PubMed - indexed for MEDLINE]
4.

Fluvoxamine versus clomipramine for obsessive-compulsive disorder: a double-blind comparison.

Koran LM, McElroy SL, Davidson JR, Rasmussen SA, Hollander E, Jenike MA.

J Clin Psychopharmacol. 1996 Apr;16(2):121-9.

PMID:
8690827
[PubMed - indexed for MEDLINE]
5.

A double-blind study of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorder.

Milanfranchi A, Ravagli S, Lensi P, Marazziti D, Cassano GB.

Int Clin Psychopharmacol. 1997 May;12(3):131-6.

PMID:
9248868
[PubMed - indexed for MEDLINE]
6.

Clomipramine in obsessive-compulsive disorder.

Katz RJ, DeVeaugh-Geiss J, Landau P.

Biol Psychiatry. 1990 Sep 1;28(5):401-14.

PMID:
2207219
[PubMed - indexed for MEDLINE]
7.

Clomipramine treatment of childhood obsessive-compulsive disorder. A double-blind controlled study.

Flament MF, Rapoport JL, Berg CJ, Sceery W, Kilts C, Mellström B, Linnoila M.

Arch Gen Psychiatry. 1985 Oct;42(10):977-83.

PMID:
3899048
[PubMed - indexed for MEDLINE]
8.

Paroxetine versus clomipramine in the treatment of obsessive-compulsive disorder. OCD Paroxetine Study Investigators.

Zohar J, Judge R.

Br J Psychiatry. 1996 Oct;169(4):468-74.

PMID:
8894198
[PubMed - indexed for MEDLINE]
9.

Venlafaxine versus clomipramine in the treatment of obsessive-compulsive disorder: a preliminary single-blind, 12-week, controlled study.

Albert U, Aguglia E, Maina G, Bogetto F.

J Clin Psychiatry. 2002 Nov;63(11):1004-9.

PMID:
12444814
[PubMed - indexed for MEDLINE]
10.

Multicentre, double-blind, comparison of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorder.

Mundo E, Maina G, Uslenghi C.

Int Clin Psychopharmacol. 2000 Mar;15(2):69-76.

PMID:
10759337
[PubMed - indexed for MEDLINE]
11.

A clomipramine dosage reduction study in the course of long-term treatment of obsessive-compulsive disorder patients.

Pato MT, Hill JL, Murphy DL.

Psychopharmacol Bull. 1990;26(2):211-4.

PMID:
2236458
[PubMed - indexed for MEDLINE]
12.

Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological results.

Pigott TA, Pato MT, Bernstein SE, Grover GN, Hill JL, Tolliver TJ, Murphy DL.

Arch Gen Psychiatry. 1990 Oct;47(10):926-32.

PMID:
2222131
[PubMed - indexed for MEDLINE]
13.

Pulse-loaded intravenous clomipramine in treatment-resistant obsessive-compulsive disorder.

Koran LM, Aboujaoude E, Ward H, Shapira NA, Sallee FR, Gamel N, Elliott M.

J Clin Psychopharmacol. 2006 Feb;26(1):79-83.

PMID:
16415712
[PubMed - indexed for MEDLINE]
14.

Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder.

Riddle MA, Scahill L, King RA, Hardin MT, Anderson GM, Ort SI, Smith JC, Leckman JF, Cohen DJ.

J Am Acad Child Adolesc Psychiatry. 1992 Nov;31(6):1062-9.

PMID:
1429406
[PubMed - indexed for MEDLINE]
15.

Long-term pharmacotherapy of obsessive-compulsive disorder: a double-blind controlled study.

Mundo E, Bareggi SR, Pirola R, Bellodi L, Smeraldi E.

J Clin Psychopharmacol. 1997 Feb;17(1):4-10. Erratum in: J Clin Psychopharmacol 1997 Oct;17(5):340. J Clin Psychopharmacol 1997 Oct;17(5):436.

PMID:
9004050
[PubMed - indexed for MEDLINE]
16.

Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents. A double-blind crossover comparison.

Leonard HL, Swedo SE, Rapoport JL, Koby EV, Lenane MC, Cheslow DL, Hamburger SD.

Arch Gen Psychiatry. 1989 Dec;46(12):1088-92.

PMID:
2686576
[PubMed - indexed for MEDLINE]
17.

Behavior therapy versus clomipramine for the treatment of obsessive-compulsive disorder in children and adolescents.

de Haan E, Hoogduin KA, Buitelaar JK, Keijsers GP.

J Am Acad Child Adolesc Psychiatry. 1998 Oct;37(10):1022-9.

PMID:
9785713
[PubMed - indexed for MEDLINE]
18.

Age onset subtypes of obsessive compulsive disorder: differences in clinical response to treatment with clomipramine.

Ulloa RE, Nicolini H, Avila M, Fernández-Guasti A.

J Child Adolesc Psychopharmacol. 2007 Feb;17(1):85-96.

PMID:
17343556
[PubMed - indexed for MEDLINE]
19.

A double-blind desipramine substitution during long-term clomipramine treatment in children and adolescents with obsessive-compulsive disorder.

Leonard HL, Swedo SE, Lenane MC, Rettew DC, Cheslow DL, Hamburger SD, Rapoport JL.

Arch Gen Psychiatry. 1991 Oct;48(10):922-7.

PMID:
1929762
[PubMed - indexed for MEDLINE]
20.

Citalopram for treatment-resistant obsessive-compulsive disorder.

Pallanti S, Quercioli L, Paiva RS, Koran LM.

Eur Psychiatry. 1999 Apr;14(2):101-6.

PMID:
10572334
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk